Wilke H J, Moench C, Lotz G, Bechstein W, Zacharowski K
Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Goethe University Hospital Frankfurt, Frankfurt, Germany.
Transplant Proc. 2011 Sep;43(7):2683-6. doi: 10.1016/j.transproceed.2011.06.029.
It is well established that patients presenting for orthotopic liver transplantation pose challenging surgical and anesthesiological problems. Intraoperatively, severe hemodynamic instability due to profuse bleeding and acute cardiomyopathy during reperfusion are major concerns. In addition, ischemia-reperfusion injury can compromise postoperative graft function. Xenon, with its potential to maintain hemodynamic stability, preserve cardiac function, and protect the liver graft of the recipient, seems to be a promising anesthetic agent for liver transplant surgery. To date, xenon has not been used as an anesthetic in liver transplantations. We therefore have reported our initial experience with four patients who underwent orthotopic deceased donor liver transplantation under xenon anesthesia. Although all patients had advanced liver disease and experienced significant intraoperative bleeding, their intraoperative courses, including reperfusion, under xenon anesthesia were remarkably stable. The patients required only moderate, temporary catecholamine support, which was withdrawn at the end of the surgery. Xenon anesthesia for liver transplant procedures proved to be feasible. Immediate postoperative organ function was satisfactory in all patients.
众所周知,接受原位肝移植的患者会带来具有挑战性的外科手术和麻醉问题。术中,大量出血导致的严重血流动力学不稳定以及再灌注期间的急性心肌病是主要关注点。此外,缺血再灌注损伤会损害术后移植物功能。氙气具有维持血流动力学稳定、保护心脏功能以及保护受体肝移植物的潜力,似乎是肝移植手术中一种有前景的麻醉剂。迄今为止,氙气尚未在肝移植中用作麻醉剂。因此,我们报告了4例在氙气麻醉下接受原位脑死亡供体肝移植患者的初步经验。尽管所有患者都患有晚期肝病且术中出血量大,但他们在氙气麻醉下的术中过程,包括再灌注,都非常稳定。患者仅需要适度的、临时的儿茶酚胺支持,在手术结束时停用。事实证明,氙气麻醉用于肝移植手术是可行的。所有患者术后即刻器官功能均令人满意。